Department of Physiological Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, United States.
Neurotoxicol Teratol. 2010 May-Jun;32(3):329-35. doi: 10.1016/j.ntt.2009.12.006. Epub 2009 Dec 23.
The comparative effects of atropine and the indirect cannabinomimetics URB597 (a fatty acid amide hydrolase inhibitor) and URB602 (a monoacylglycerol lipase inhibitor) on functional and neurobehavioral endpoints following acute diisopropylfluorophosphate intoxication were studied. Male Sprague-Dawley rats were treated with vehicle or DFP (2.5mg/kg, sc), immediately post-treated with either vehicle, atropine (16mg/kg), URB597 (3mg/kg), URB602 (10mg/kg) or a combination of URB597 and URB602, and functional signs of toxicity as well as nocturnal motor activity were measured daily for seven consecutive days. Performance in the elevated plus maze (for anxiety-like behavior) and the forced swimming test (for depression-like behavior) was measured at days 6-8 and 27-29 after dosing. Twenty-four hours after dosing, DFP markedly reduced cholinesterase activity in selected brain regions and peripheral tissues (diaphragm and plasma). Substantial recovery of cholinesterase activity was noted at both 8 and 29days after dosing but significant inhibition was still noted in some brain regions at the latest time-point. DFP elicited body weight reductions and typical signs of cholinergic toxicity, and reduced nocturnal ambulation and rearing. Atropine and the cannabinomimetics (alone and in combination) partially attenuated DFP-induced functional signs of toxicity. None of the post-treatments reversed the DFP-induced reduction in ambulation or rearing, however. No significant treatment-related effects on elevated plus maze performance were noted. DFP-treated rats exhibited decreased swimming and increased immobility in the forced swimming test at both time-points. None of the post-treatments had any effect on DFP-induced changes in immobility or swimming at day 8. At day 29, atropine and the combination of URB597/URB602 significantly blocked DFP-induced changes in immobility, while URB597 and the combination reversed DFP-induced changes in swimming. The results suggest that early blockade of muscarinic receptors and enhancement of eCB signaling can attenuate both acute and delayed effects elicited by DFP.
研究了阿托品和间接大麻素类似物 URB597(脂肪酸酰胺水解酶抑制剂)和 URB602(单酰基甘油脂肪酶抑制剂)在急性敌敌畏中毒后对功能和神经行为终点的比较影响。雄性 Sprague-Dawley 大鼠用载体或 DFP(2.5mg/kg,sc)处理,立即用载体、阿托品(16mg/kg)、URB597(3mg/kg)、URB602(10mg/kg)或 URB597 和 URB602 的组合处理,每天连续 7 天测量毒性的功能体征和夜间运动活动。在给药后第 6-8 天和第 27-29 天测量高架十字迷宫(用于焦虑样行为)和强迫游泳试验(用于抑郁样行为)的表现。给药后 24 小时,DFP 明显降低选定脑区和外周组织(膈肌和血浆)中的胆碱酯酶活性。在给药后 8 天和 29 天均观察到胆碱酯酶活性的大量恢复,但在最新时间点仍观察到一些脑区的显著抑制。DFP 引起体重减轻和典型的胆碱能毒性迹象,并减少夜间走动和直立。阿托品和大麻素类似物(单独和组合)部分减轻了 DFP 引起的毒性功能体征。然而,没有一种后处理逆转 DFP 引起的走动或直立减少。没有观察到与处理相关的对高架十字迷宫表现的显著影响。DFP 处理的大鼠在两个时间点的强迫游泳试验中均表现出游泳减少和不动增加。在第 8 天,没有任何后处理对 DFP 引起的不动或游泳变化有任何影响。在第 29 天,阿托品和 URB597/URB602 的组合显著阻断了 DFP 引起的不动变化,而 URB597 和组合逆转了 DFP 引起的游泳变化。结果表明,早期阻断毒蕈碱受体和增强内源性大麻素信号可以减轻 DFP 引起的急性和迟发性效应。